Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection

Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of usin...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of hospital infection Vol. 107; pp. 40 - 44
Main Authors Takenouchi, T., Iwasaki, Y.W., Harada, S., Ishizu, H., Uwamino, Y., Uno, S., Osada, A., Abe, K., Hasegawa, N., Murata, M., Takebayashi, T., Fukunaga, K., Saya, H., Kitagawa, Y., Amagai, M., Siomi, H., Kosaki, K.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.01.2021
Published by Elsevier Ltd on behalf of The Healthcare Infection Society
Subjects
Online AccessGet full text
ISSN0195-6701
1532-2939
1532-2939
DOI10.1016/j.jhin.2020.10.014

Cover

Abstract Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.
AbstractList Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.
COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.
COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters #1 or #2. These patients, who had no clear history of infectious contact within the hospital ("undetermined source of infection"), had haplotypes similar to those in cluster #2 but did not have two of the mutations used to characterize cluster #2, suggesting that these 14 cases of "undetermined source of infection" were not derived from cluster #2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.
SummaryCoronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We conducted the present study to evaluate the efficacy of using whole genome sequencing to determine the source of infection in hospitalized patients who do not have a clear infectious contact history. Recently, we encountered two seemingly separate COVID-19 clusters in a tertiary hospital. Whole viral genome sequencing distinguished the two clusters according to the viral haplotype. However, the source of infection was unclear in 14 patients with COVID-19 who were clinically unlinked to clusters 1 or 2. These patients, who had no clear history of infectious contact within the hospital (‘undetermined source of infection’), had haplotypes similar to those in cluster 2 but did not have two of the mutations used to characterize cluster 2, suggesting that these 14 cases of ‘undetermined source of infection’ were not derived from cluster 2. Whole viral genome sequencing can be useful for confirming that sporadic COVID-19 cases with an undetermined source of infection are indeed not part of clusters at the institutional level.
Author Kosaki, K.
Takenouchi, T.
Fukunaga, K.
Murata, M.
Kitagawa, Y.
Abe, K.
Osada, A.
Ishizu, H.
Iwasaki, Y.W.
Hasegawa, N.
Uwamino, Y.
Amagai, M.
Uno, S.
Saya, H.
Siomi, H.
Takebayashi, T.
Harada, S.
Author_xml – sequence: 1
  givenname: T.
  surname: Takenouchi
  fullname: Takenouchi, T.
  organization: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
– sequence: 2
  givenname: Y.W.
  surname: Iwasaki
  fullname: Iwasaki, Y.W.
  organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan
– sequence: 3
  givenname: S.
  surname: Harada
  fullname: Harada, S.
  organization: Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan
– sequence: 4
  givenname: H.
  surname: Ishizu
  fullname: Ishizu, H.
  organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan
– sequence: 5
  givenname: Y.
  surname: Uwamino
  fullname: Uwamino, Y.
  organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan
– sequence: 6
  givenname: S.
  surname: Uno
  fullname: Uno, S.
  organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan
– sequence: 7
  givenname: A.
  surname: Osada
  fullname: Osada, A.
  organization: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
– sequence: 8
  givenname: K.
  surname: Abe
  fullname: Abe, K.
  organization: Department of Surgery, Keio University School of Medicine, Tokyo, Japan
– sequence: 9
  givenname: N.
  surname: Hasegawa
  fullname: Hasegawa, N.
  organization: Division of Infectious Diseases and Infection Control, Keio University Hospital, Tokyo, Japan
– sequence: 10
  givenname: M.
  surname: Murata
  fullname: Murata, M.
  organization: Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan
– sequence: 11
  givenname: T.
  surname: Takebayashi
  fullname: Takebayashi, T.
  organization: Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan
– sequence: 12
  givenname: K.
  surname: Fukunaga
  fullname: Fukunaga, K.
  organization: Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
– sequence: 13
  givenname: H.
  surname: Saya
  fullname: Saya, H.
  organization: Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan
– sequence: 14
  givenname: Y.
  surname: Kitagawa
  fullname: Kitagawa, Y.
  organization: Department of Surgery, Keio University School of Medicine, Tokyo, Japan
– sequence: 15
  givenname: M.
  surname: Amagai
  fullname: Amagai, M.
  organization: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
– sequence: 16
  givenname: H.
  surname: Siomi
  fullname: Siomi, H.
  email: awa403@keio.jp
  organization: Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan
– sequence: 17
  givenname: K.
  surname: Kosaki
  fullname: Kosaki, K.
  email: kkosaki@keio.jp
  organization: Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34756867$$D View this record in MEDLINE/PubMed
BookMark eNqFklFrFDEUhYNU7Lb6B3yQefRl1ptkkpkRKZTFqlAQXBV8CrPJnd2Ms8k2mansv2-G3YoWrE8hN_ecQ-53z8iJ8w4JeUlhToHKN92821g3Z8Cmwhxo8YTMqOAsZzWvT8gMaC1yWQI9JWcxdgCQ6uIZOeVFKWQlyxn5seits7rps3GwvR32mW-z5eWXZb7w33OW_dr4HrM1Or_FLOLNiE5bt86sywxqu9tgmK7Rj0HjpLWuRT1Y756Tp23TR3xxPM_Jt6v3Xxcf8-vPHz4tLq9zLSQd8qKSUBoAYSpJeQllU-qagxGI0mDR1pxTURgwGlfSCKhXhkkmUDMqoGSSn5OLg-9uXG0xtbkhNL3aBbttwl75xqq_X5zdqLW_VaWoRFGzZPD6aBB8-l8c1NZGjX3fOPRjVEzUEiivappaX_2Z9Tvkfp6poTo06OBjDNgqbYdmGkeKtr2ioCZ0qlMTOjWhm2oJXZKyB9J790dF7w4iTBO-tRhU1DYhQmNDwqCMt4_LLx7I9XEdfuIeY5eousROURWZArWcFmraJwYcilrwZPD23wb_S78DR0Hakg
CitedBy_id crossref_primary_10_1097_MD_0000000000028398
crossref_primary_10_1055_s_0041_1736561
crossref_primary_10_7883_yoken_JJID_2021_841
crossref_primary_10_1016_j_jhin_2023_08_002
crossref_primary_10_7717_peerj_13132
crossref_primary_10_2302_kjm_kjm_covid19_01
crossref_primary_10_1016_j_infpip_2021_100190
crossref_primary_10_1038_s41598_022_05424_3
crossref_primary_10_1016_j_jhin_2021_05_017
crossref_primary_10_7883_yoken_JJID_2023_464
crossref_primary_10_1016_j_jcv_2021_104877
crossref_primary_10_1016_j_tmaid_2021_102210
crossref_primary_10_7717_peerj_cs_1479
crossref_primary_10_1093_ofid_ofab120
crossref_primary_10_1093_infdis_jiad074
crossref_primary_10_2302_kjm_2021_0005_OA
Cites_doi 10.7883/yoken.JJID.2020.061
10.1093/bioinformatics/btp352
10.1016/j.cell.2020.06.043
10.15585/mmwr.mm6912e3
10.1093/bioinformatics/bty407
10.1186/s13059-018-1618-7
10.1002/gch2.1018
10.1038/s41586-020-2008-3
10.1016/j.ijid.2020.06.027
10.4161/fly.19695
10.1093/bioinformatics/btv566
10.1093/bioinformatics/btp324
ContentType Journal Article
Copyright 2020
Copyright © 2020. Published by Elsevier Ltd.
2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2020
Copyright_xml – notice: 2020
– notice: Copyright © 2020. Published by Elsevier Ltd.
– notice: 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2020
CorporateAuthor Keio Donner Project
CorporateAuthor_xml – name: Keio Donner Project
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1016/j.jhin.2020.10.014
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1532-2939
EndPage 44
ExternalDocumentID PMC7585492
34756867
10_1016_j_jhin_2020_10_014
S0195670120304953
1_s2_0_S0195670120304953
Genre Journal Article
GroupedDBID ---
--K
--M
..I
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABAOU
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADGUI
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ARUGR
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LUGTX
M29
M41
MHUIS
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSI
SSZ
T5K
UHS
UV1
WOW
WUQ
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
NPM
7X8
ACLOT
~HD
5PM
ID FETCH-LOGICAL-c561t-48607d005d8613707a7c930d5ee6de4f933154d0dceb6d509bd2625ec21507263
IEDL.DBID AIKHN
ISSN 0195-6701
1532-2939
IngestDate Thu Aug 21 14:13:05 EDT 2025
Sat Sep 27 20:06:44 EDT 2025
Fri Apr 04 01:34:05 EDT 2025
Thu Apr 24 23:00:48 EDT 2025
Tue Jul 01 03:53:55 EDT 2025
Fri Feb 23 02:47:38 EST 2024
Tue Feb 25 20:08:53 EST 2025
Tue Aug 26 20:34:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
Nosocomial infection
SARS-CoV-2
Community infection
Whole genome sequencing
Language English
License Copyright © 2020. Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c561t-48607d005d8613707a7c930d5ee6de4f933154d0dceb6d509bd2625ec21507263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7585492
PMID 34756867
PQID 2596013891
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7585492
proquest_miscellaneous_2596013891
pubmed_primary_34756867
crossref_citationtrail_10_1016_j_jhin_2020_10_014
crossref_primary_10_1016_j_jhin_2020_10_014
elsevier_sciencedirect_doi_10_1016_j_jhin_2020_10_014
elsevier_clinicalkeyesjournals_1_s2_0_S0195670120304953
elsevier_clinicalkey_doi_10_1016_j_jhin_2020_10_014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Journal of hospital infection
PublicationTitleAlternate J Hosp Infect
PublicationYear 2021
Publisher Elsevier Ltd
Published by Elsevier Ltd on behalf of The Healthcare Infection Society
Publisher_xml – name: Elsevier Ltd
– name: Published by Elsevier Ltd on behalf of The Healthcare Infection Society
References Moriarty, Plucinski, Marston, Kurbatova, Knust, Murray (bib13) 2020; 69
Quick (bib6) 2020; vol. 1
Li, Durbin (bib7) 2009; 25
Korber, Fischer, Gnanakaran, Yoon, Theiler, Abfalterer (bib14) 2020; 182
Grubaugh, Gangavarapu, Quick, Matteson, De Jesus, Main (bib9) 2019; 20
Okonechnikov, Conesa, Garcia-Alcalde (bib10) 2016; 32
Elbe, Buckland-Merrett (bib2) 2017; 1
Hadfield, Megill, Bell, Huddleston, Potter, Callender (bib3) 2018; 34
Wu, Zhao, Yu, Chen, Wang, Song (bib8) 2020; 579
Shirato, Nao, Katano, Takayama, Saito, Kato (bib4) 2020; 73
Cingolani, Platts, Wang le, Coon, Nguyen, Wang (bib12) 2012; 6
Artic ncov-2019 primers, version 3. 2020.
Penarrubia, Ruiz, Porco, Rao, Juanola-Falgarona, Manissero (bib1) 2020; 97
Li, Handsaker, Wysoker, Fennell, Ruan, Homer (bib11) 2009; 25
Li (10.1016/j.jhin.2020.10.014_bib7) 2009; 25
Okonechnikov (10.1016/j.jhin.2020.10.014_bib10) 2016; 32
Korber (10.1016/j.jhin.2020.10.014_bib14) 2020; 182
Grubaugh (10.1016/j.jhin.2020.10.014_bib9) 2019; 20
Moriarty (10.1016/j.jhin.2020.10.014_bib13) 2020; 69
Cingolani (10.1016/j.jhin.2020.10.014_bib12) 2012; 6
Penarrubia (10.1016/j.jhin.2020.10.014_bib1) 2020; 97
10.1016/j.jhin.2020.10.014_bib5
Hadfield (10.1016/j.jhin.2020.10.014_bib3) 2018; 34
Shirato (10.1016/j.jhin.2020.10.014_bib4) 2020; 73
Wu (10.1016/j.jhin.2020.10.014_bib8) 2020; 579
Quick (10.1016/j.jhin.2020.10.014_bib6) 2020; vol. 1
Elbe (10.1016/j.jhin.2020.10.014_bib2) 2017; 1
Li (10.1016/j.jhin.2020.10.014_bib11) 2009; 25
References_xml – volume: 32
  start-page: 292
  year: 2016
  end-page: 294
  ident: bib10
  article-title: Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
  publication-title: Bioinformatics
– volume: 73
  start-page: 304
  year: 2020
  end-page: 307
  ident: bib4
  article-title: Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan
  publication-title: Jpn J Infect Dis
– volume: 579
  start-page: 265
  year: 2020
  end-page: 269
  ident: bib8
  article-title: A new coronavirus associated with human respiratory disease in China
  publication-title: Nature
– volume: 20
  start-page: 8
  year: 2019
  ident: bib9
  article-title: An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
  publication-title: Genome Biol
– volume: 69
  start-page: 347
  year: 2020
  end-page: 352
  ident: bib13
  article-title: Public health responses to COVID-19 outbreaks on cruise ships – worldwide, February–March 2020
  publication-title: Morb Mortal Wkly Rep
– volume: 97
  start-page: 225
  year: 2020
  end-page: 229
  ident: bib1
  article-title: Multiple assays in a real-time RT–PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
  publication-title: Int J Infect Dis
– volume: 34
  start-page: 4121
  year: 2018
  end-page: 4123
  ident: bib3
  article-title: Nextstrain: real-time tracking of pathogen evolution
  publication-title: Bioinformatics
– volume: vol. 1
  year: 2020
  ident: bib6
  publication-title: nCoV-2019 sequencing protocol
– volume: 6
  start-page: 80
  year: 2012
  end-page: 92
  ident: bib12
  article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of
  publication-title: Fly (Austin)
– volume: 25
  start-page: 2078
  year: 2009
  end-page: 2079
  ident: bib11
  article-title: The Sequence Alignment/Map format and SAMtools
  publication-title: Bioinformatics
– volume: 1
  start-page: 33
  year: 2017
  end-page: 46
  ident: bib2
  article-title: Data, disease and diplomacy: GISAID’s innovative contribution to global health
  publication-title: Glob Chall
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  ident: bib7
  article-title: Fast and accurate short read alignment with Burrows–Wheeler transform
  publication-title: Bioinformatics
– volume: 182
  start-page: 812
  year: 2020
  end-page: 827 e19
  ident: bib14
  article-title: Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
  publication-title: Cell
– reference: Artic ncov-2019 primers, version 3. 2020.
– volume: 73
  start-page: 304
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib4
  article-title: Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2020.061
– volume: 25
  start-page: 2078
  year: 2009
  ident: 10.1016/j.jhin.2020.10.014_bib11
  article-title: The Sequence Alignment/Map format and SAMtools
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp352
– volume: 182
  start-page: 812
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib14
  article-title: Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.043
– volume: 69
  start-page: 347
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib13
  article-title: Public health responses to COVID-19 outbreaks on cruise ships – worldwide, February–March 2020
  publication-title: Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6912e3
– volume: 34
  start-page: 4121
  year: 2018
  ident: 10.1016/j.jhin.2020.10.014_bib3
  article-title: Nextstrain: real-time tracking of pathogen evolution
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty407
– volume: 20
  start-page: 8
  year: 2019
  ident: 10.1016/j.jhin.2020.10.014_bib9
  article-title: An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
  publication-title: Genome Biol
  doi: 10.1186/s13059-018-1618-7
– volume: 1
  start-page: 33
  year: 2017
  ident: 10.1016/j.jhin.2020.10.014_bib2
  article-title: Data, disease and diplomacy: GISAID’s innovative contribution to global health
  publication-title: Glob Chall
  doi: 10.1002/gch2.1018
– volume: 579
  start-page: 265
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib8
  article-title: A new coronavirus associated with human respiratory disease in China
  publication-title: Nature
  doi: 10.1038/s41586-020-2008-3
– volume: 97
  start-page: 225
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib1
  article-title: Multiple assays in a real-time RT–PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2020.06.027
– volume: 6
  start-page: 80
  year: 2012
  ident: 10.1016/j.jhin.2020.10.014_bib12
  article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
  publication-title: Fly (Austin)
  doi: 10.4161/fly.19695
– volume: 32
  start-page: 292
  year: 2016
  ident: 10.1016/j.jhin.2020.10.014_bib10
  article-title: Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv566
– volume: vol. 1
  year: 2020
  ident: 10.1016/j.jhin.2020.10.014_bib6
– volume: 25
  start-page: 1754
  year: 2009
  ident: 10.1016/j.jhin.2020.10.014_bib7
  article-title: Fast and accurate short read alignment with Burrows–Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– ident: 10.1016/j.jhin.2020.10.014_bib5
SSID ssj0009395
Score 2.42233
Snippet Coronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the standpoint of...
SummaryCoronavirus disease 2019 (COVID-19) caused by human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide problem. From the...
COVID-19 caused by SARS-CoV-2 is a worldwide problem. From the standpoint of hospital infection control, determining the source of infection is critical. We...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 40
SubjectTerms Community infection
COVID-19
Infectious Disease
Nosocomial infection
SARS-CoV-2
Short Report
Whole genome sequencing
Title Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0195670120304953
https://www.clinicalkey.es/playcontent/1-s2.0-S0195670120304953
https://dx.doi.org/10.1016/j.jhin.2020.10.014
https://www.ncbi.nlm.nih.gov/pubmed/34756867
https://www.proquest.com/docview/2596013891
https://pubmed.ncbi.nlm.nih.gov/PMC7585492
Volume 107
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9t3QsSQnxTPiYj8Ya8xnZip49VxVSo2MPKYDxZSexumUZa0U688bdzFzuFMhgST5Ecn2Jfzr7f2fcB8MqkPsuFF1wVyZwTYOelyQuuDZospanyQlCA8_sjPTlJ351mpzsw7mJhyK0y7v1hT29369gyiNwcLOt6MGtD3QwFf9JVUaZ2YU-its97sDd6O50c_cy9q4ZZV5aQCGLsTHDzujivKQ2qpIaDRKR_00_X8efvbpS_6KXDu3AnAko2CmO-Bzu-uQ-3w2kcC0FGD-BzTP95yVDOCHizxZzNRsczPl585JJ9oyq5jPK1fvEselejTmN1w5yv6mUbJHjGwkk_0XY-XM1DODl882E84bGoAq8QKq05FZ0yDteey1GTm8QUphqqxGXea-fT-VApRFUuwVmV2iGcKJ1EG8lXkqCj1OoR9JpF458AEyXqfi2cz9GoKrwssd88rTJkrBNpJfogOlbaKmYcp8IXl7ZzLbuwxH5L7Kc2ZH8fXm9oliHfxo29VfeHbBdJinufRXVwI5X5E5VfxeW7ssKupE3sNRHrQ7ah3JLSf37xZSc-Fpcv3ckUjV9crSxanzpcFvfhcRCnzbxVajKda4Pj3RK0TQdKDb79pqnP2xThZAWmQ_n0P8f7DG5J8t1pj5qeQ2_99cq_QPC1Lvdh9-C72I9LjJ7T40_TH9bfLdk
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-N7gEkhPimfBqJNxQaf8ROH6uKqWNbH-iGxpOVxC7LNNKKduLf5y52CmUwJF4dn-Jc7ny_s-8D4I1RPsu554ks0nlCgD0pTV4k2qDLUpoqLzglOB9N9eREfTjNTndg3OXCUFhl3PvDnt7u1nFkELk5WNb1YNamuhlK_qSrokzegF1FTa17sDvaP5hMf9belcOsa0tIBDF3JoR5nZ_VVAZV0MC7lKu_2aer-PP3MMpf7NLeXbgTASUbhTXfgx3f3Ifb4TSOhSSjB_A5lv-8YChnBLzZYs5mo4-zZLz4lAj2nbrkMqrX-tWzGF2NNo3VDXO-qpdtkuAXFk76ibaL4Woewsne--PxJIlNFZIKodI6oaZTxqHuuRwtuUlNYaqhTF3mvXZezYdSIqpyKX5VqR3CidIJ9JF8JQg6Ci0fQa9ZNP4JMF6i7dfc-RydqsKLEufNVZUhYx1XFe8D71hpq1hxnBpfXNgutOzcEvstsZ_GkP19eLuhWYZ6G9fOlt0fsl0mKe59Fs3BtVTmT1R-FdV3ZbldCZvaKyLWh2xDuSWl_3zj6058LKov3ckUjV9crix6nzpcFvfhcRCnzXdLZTKda4Pr3RK0zQQqDb79pKnP2hLh5AWqoXj6n-t9BTcnx0eH9nB_evAMbgmK42mPnZ5Db_3t0r9AILYuX0ZF-wF9my4c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+utility+of+SARS-CoV-2+whole+genome+sequencing+in+deciphering+source+of+infection&rft.jtitle=The+Journal+of+hospital+infection&rft.au=Takenouchi%2C+T.&rft.au=Iwasaki%2C+Y.W.&rft.au=Harada%2C+S.&rft.au=Ishizu%2C+H.&rft.date=2021-01-01&rft.pub=Elsevier+Ltd&rft.issn=0195-6701&rft.eissn=1532-2939&rft.volume=107&rft.spage=40&rft.epage=44&rft_id=info:doi/10.1016%2Fj.jhin.2020.10.014&rft.externalDocID=S0195670120304953
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01956701%2Fcov200h.gif